Pregnancy, Ectopic: Clinical Trials

6 trials for Pregnancy, Ectopic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 active not recruiting. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 3, Unknown 2, Active not recruiting 1
Phase 21Active not recruiting 1

Follow Pregnancy, Ectopic: new trials by email Literature Review of Pregnancy, Ectopic trials Research Report on Pregnancy, Ectopic

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential vs. Combined Letrozole and Methotrexate for Tubal Ectopic Pregnancy.
Letrozole, Methotrexate - Ectopic Pregnancy
Phase 2 / Phase 3Active not recruitingBenha University1442024-12-152026-09-25
Letrozole in Tubal Ectopic Pregnancy
Placebos, Letrozole tablets - Tubal Pregnancy
Phase 3UnknownQueen Mary Hospital, Hong Kong2142020-12-012023-04-10
Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix
Degarelix - Pregnancy, Ovarian
Phase 3UnknownAssisting Nature1202017-02-152020-10-08
Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
Methotrexate, Uterine Evacuation, Expectant Management - Persistent Pregnancy of Unknown Location, Ectopic Pregnancy
Phase 3CompletedYale University2552014-07-252020-12-08
Methotrexate Treatment for Ectopic Pregnancy
Single-dose Methotrexate, Two-dose methotrexate protocol - Ectopic Pregnancy
Phase 3CompletedCHA University922013-05-012016-01-22
Two-Dose Methotrexate for Ectopic Pregnancy
Methotrexate - Ectopic Pregnancy
Phase 3CompletedUniversity of Pennsylvania1002001-03-012011-08-09

Narrower conditions

Pregnancy, Ovarian (1)  ·  Pregnancy, Tubal (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (6)  ·  Pregnancy Complications (6)  ·  Urogenital Diseases (6)

Interventions

Methotrexate (4)  ·  Letrozole (2)  ·  Watchful Waiting (1)  ·  acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (1)

Sponsors

Assisting Nature (1)  ·  Benha University (1)  ·  CHA University (1)  ·  Queen Mary Hospital, Hong Kong (1)  ·  University of Pennsylvania (1)  ·  Yale University (1)

Countries

United States (2)  ·  Egypt (1)  ·  Greece (1)  ·  Hong Kong (1)  ·  South Korea (1)

Top investigators

Anne Steiner, MD MPH (1)  ·  Christos Coutifaris, MD PhD (1)  ·  Ernest H.Y. Ng, MD (1)  ·  Esther Eisenberg, MD MPH (1)  ·  Evaggelos Papanikolaou, MD, PhD (1)  ·  Heping Zhang, PhD (1)  ·  Karl Hansen, MD PhD (1)  ·  Kurt Barnhart, MD MSCE (1)  ·  Kurt T Barnhart, MD, MSCE (1)  ·  Marcelle Cedars, MD (1)  ·  Michael Diamond, MD (1)  ·  Nanette Santoro, MD (1)  ·  Richard Legro, MD (1)  ·  Robert Najdecki, MD, PhD (1)  ·  Taejong Song, M.D. (1)

Results publications

PMID 26701971, PMID 29545772, PMID 34342619

NIH funding

U10HD055925 (1)